Objective: This study aimed to examine the influence of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser irradiation on equine bone marrow-derived mesenchymal stem cell (MSC) viability, proliferation, and cytokine expression in vitro. Background: Photobiomodulation of cells using monochromatic light is a technique designed to influence cellular processes. Previous studies have shown dose-dependent effects of low-level laser irradiation on cell proliferation and cytokine expression in a range of cell types and species. Evidence for the influence of 1064 nm wavelength near-infrared irradiation on MSCs is sparse, and high-energy doses have shown inhibitory effects. Methods: MSC cultures from six horses were exposed to 1064 nm irradiation with an energy density of 9.77 J/cm2 and a mean output power of 13.0 W for 10 sec. MSC viability and proliferation were evaluated through flow cytometry and real-time live cell analysis. Gene expression and cytokine production in the first 24 h after irradiation were analyzed through polymerase chain reaction (PCR), multiplex assay, and enzyme-linked immunosorbent assay. Results: No difference in viability was detected between irradiated and control MSCs. Irradiated cells demonstrated slightly lower proliferation rates, but remained within 3.5% confluence of control cells. Twenty-four hours after irradiation, irradiated MSCs demonstrated a significant increase in expression of interleukin (IL)-10 and vascular endothelial growth factor (VEGF) compared with control MSCs. Conclusions: Under these irradiation parameters, equine MSCs remained viable and expressed increased concentrations of IL-10 and VEGF. IL-10 has an anti-inflammatory action by inhibiting the synthesis of proinflammatory cytokines at the transcriptional level. This response to 1064 nm irradiation shows promise in the photobiomodulation of MSCs to enhance their therapeutic properties.
Get full access to this article
View all access options for this article.
References
1.
WuY-h, WangJ, GongD-x, GuH-y, HuS-s, ZhangH. Effects of low-level laser irradiation on mesenchymal stem cell proliferation: a microarray analysis. Lasers Med Sci, 2012; 27:509–519.
2.
MesterE, MesterAF, MesterA. The biomedical effects of laser application. Lasers Surg Med, 1985; 5:31–39.
3.
SchneedeP, JelkmannW, SchrammU, FrickeH, SteinmetzM, HofstetterA. Effects of the helium-neon laser on rat kidney epithelial cells in culture. Lasers Med Sci, 1988; 3:249–257.
4.
GaoX, XingD. Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci, 2009; 16:4.
5.
PeplowPV, ChungT-Y, RyanB, BaxterGD. Laser photobiomodulation of gene expression and release of growth factors and cytokines from cells in culture: a review of human and animal studies. Photomed Laser Surg, 2011; 29:285–304.
6.
KaruTI. Cellular and molecular mechanisms of photobiomodulation (low-power laser therapy). IEEE J Sel Top Quantum Electron, 2014; 20:143–148.
7.
TubyH, MaltzL, OronU. Low-level laser irradiation (LLLI) promotes proliferation of mesenchymal and cardiac stem cells in culture. Lasers Surg Med, 2007; 39:373–378.
8.
SoleimaniM, AbbasniaE, FathiM, SahraeiH, FathiY, KakaG. The effects of low-level laser irradiation on differentiation and proliferation of human bone marrow mesenchymal stem cells into neurons and osteoblasts—an in vitro study. Lasers Med Sci, 2012; 27:423–430.
9.
Horvát-KarajzK, BaloghZ, KovácsV, drRerNatAH, SréterL, UherF. In vitro effect of carboplatin, cytarabine, paclitaxel, vincristine, and low-power laser irradiation on murine mesenchymal stem cells. Lasers Surg Med, 2009; 41:463–469.
10.
PereiraAN, EduardoCdP, MatsonE, MarquesMM. Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med, 2002; 31:263–267.
11.
AlGhamdiKM, KumarA, MoussaNA. Low-level laser therapy: a useful technique for enhancing the proliferation of various cultured cells. Lasers Med Sci, 2012; 27:237–249.
12.
AngelovaA, IlievaEM. Effectiveness of high intensity laser therapy for reduction of pain in knee osteoarthritis. Pain Res Manag, 2016; 2016:1–11.
13.
KapoorM, Martel-PelletierJ, LajeunesseD, PelletierJ-P, FahmiH. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol, 2011; 7:33–42.
14.
SaklatvalaJ. Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature, 1986; 322:547–549.
15.
TowleCA, HungHH, BonassarLJ, TreadwellBV, ManghamDC. Detection of interleukin-1 in the cartilage of patients with osteoarthritis: a possible autocrine/paracrine role in pathogenesis. Osteoarthritis Cartilage, 1997; 5:293–300.
FernandesJC, Martel‐PelletierJ, PelletierJP. The role of cytokines in osteoarthritis pathophysiology. Biorheology, 2002; 39:237–246.
18.
ZhangX, MaoZ, YuC. Suppression of early experimental osteoarthritis by gene transfer of interleukin‐1 receptor antagonist and interleukin‐10. J Orthop Res, 2004; 22:742–750.
19.
JovanovicDV, Di BattistaJA, Martel-PelletierJ, et al.IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J Immunol, 1998; 160:3513–3521.
20.
AimbireF, AlbertiniR, PachecoM, et al.Low-level laser therapy induces dose-dependent reduction of TNFα levels in acute inflammation. Photomed Laser Surg, 2006; 24:33–37.
21.
KisidayJD, GoodrichLR, McIlwraithCW, FrisbieDD. Effects of equine bone marrow aspirate volume on isolation, proliferation, and differentiation potential of mesenchymal stem cells. Am J Vet Res, 2013; 74:801–807.
22.
TatulloM, MarrelliM, FalisiG, et al.Mechanical Influence of Tissue Culture Plates and Extracellular Matrix on Mesenchymal Stem Cell Behavior: A Topical Review. London, England: SAGE Publications, 2016.
23.
DudakovicA, CamilleriE, RiesterSM, et al.High‐resolution molecular validation of self‐renewal and spontaneous differentiation in clinical‐grade adipose‐tissue derived human mesenchymal stem cells. J Cell Biochem, 2014; 115:1816–1828.
24.
BellayrIH, MarkleinRA, Lo SurdoJL, BauerSR, PuriRK. Identification of predictive gene markers for multipotent stromal cell proliferation. Stem Cells Dev, 2016; 25:861–873.
25.
WagnerB, FreerH. Development of a bead-based multiplex assay for simultaneous quantification of cytokines in horses. Vet Immunol Immunopathol, 2009; 127:242–248.
26.
LiuH, KemenyDM, HengBC, OuyangHW, MelendezAJ, CaoT. The immunogenicity and immunomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol, 2006; 176:2864–2871.
27.
PonceletAJ, VercruysseJ, SaliezA, GianelloP. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation, 2007; 83:783–790.
28.
AsadullahK, SterryW, VolkH. Interleukin-10 therapy—review of a new approach. Pharmacol Rev, 2003; 55:241–269.
29.
BogdanC, PaikJ, VodovotzY, NathanC. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem, 1992; 267:23301–23308.
FiorentinoDF, BondMW, MosmannT. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med, 1989; 170:2081–2095.
32.
de Waal MalefytR, AbramsJ, BennettB, FigdorCG, De VriesJE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med, 1991; 174:1209–1220.
33.
Martel-PelletierJ, AlaaeddineN, PelletierJ-P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci, 1999; 4:D694–D703.
34.
KollsJK, LindénA. Interleukin-17 family members and inflammation. Immunity, 2004; 21:467–476.
35.
FerraraN, Davis-SmythT. The biology of vascular endothelial growth factor. Endocr Rev, 1997; 18:4–25.
36.
FerraraN, GerberH-P, LeCouterJ. The biology of VEGF and its receptors. Nat Med, 2003; 9:669–676.
37.
LingarajK, PohCK, WangW. Vascular endothelial growth factor (VEGF) is expressed during articular cartilage growth and re-expressed in osteoarthritis. Ann Acad Med Singapore, 2010; 39:399.
38.
MatsumotoT, Claesson-WelshL. VEGF receptor signal transduction. Sci STKE, 2001; re21.
39.
TammelaT, EnholmB, AlitaloK, PaavonenK. The biology of vascular endothelial growth factors. Cardiovasc Res, 2005; 65:550–563.
40.
ClaussM, GerlachM, GerlachH, et al.Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med, 1990; 172:1535–1545.
41.
MarrelliM, TatulloM. Influence of PRF in the healing of bone and gingival tissues. Clinical and histological evaluations. Eur Rev Med Pharmacol Sci, 2013; 17:1958–1962.
42.
MayerH, BertramH, LindenmaierW, KorffT, WeberH, WeichH. Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem, 2005; 95:827–839.
43.
SteinbrechDS, MehraraBJ, SaadehPB, et al.VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol, 2000; 278:C853–C860.
44.
AkenoN, Czyzyk-KrzeskaMF, GrossTS, ClemensTL. Hypoxia induces vascular endothelial growth factor gene transcription in human osteoblast-like cells through the hypoxia-inducible factor-2α. Endocrinology, 2001; 142:959–962.
TatulloM, SimoneGM, TarulloF, et al.Antioxidant and antitumor activity of a bioactive polyphenolic fraction isolated from the brewing process. Sci Rep, 2016; 6:36042.
47.
FortunaD, RossiG, PaoliniC, et al.Nd: YAG pulsed-wave laser as support therapy in the treatment of teno-desmopathies of athlete horses: a clinical and experimental trial. In: Laser Florence 2001: A Window on the Laser Medicine World. International Society for Optics and Photonics, Florence, Italy, 2002; pp. 105–118.
48.
HrnjakM, Kuljić-KapulicaN, BudisinA, GiserA. Stimulatory effect of low-power density He-Ne laser radiation on human fibroblasts in vitro. Vojnosanitetski Pregled, 1994; 52:539–546.
49.
GutknechtN, KanehlS, MoritzA, MittermayerC, LampertF. Effects of Nd: YAG‐laser irradiation on monolayer cell cultures. Lasers Surg Med, 1998; 22:30–36.
50.
AbergelRP, MeekerCA, DwyerRM, LesavoyMA, UittoJ. Nonthermal effects of Nd: YAG laser on biological functions of human skin fibroblasts in culture. Lasers Surg Med, 1984; 3:279–284.
51.
BasfordJR. Low intensity laser therapy: still not an established clinical tool. Lasers Surg Med, 1995; 16:331–342.
52.
CarradeDD, BorjessonDL. Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med, 2013; 63:207–217.
53.
FrisbieDD, KawcakCE, WerpyNM, ParkRD, McIlwraithCW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res, 2007; 68:290–296.
